SANA
Sana Biotechnology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$904.47M
P/E Ratio
—
EPS
$-0.96
Beta
2.06
52W High
$6.55
52W Low
$1.60
50-Day MA
$3.43
200-Day MA
$3.97
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Sana Biotechnology Inc
Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-178.21M |
| Operating Margin | 0.00% |
| Return on Equity | -118.70% |
| Return on Assets | -26.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.60 |
| Price-to-Book | 5.62 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -1.08 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $269.99M |
| Float | $179.69M |
| % Insiders | 6.61% |
| % Institutions | 75.17% |
Historical Volatility
HV 10-Day
66.34%
HV 20-Day
67.06%
HV 30-Day
69.50%
HV 60-Day
76.85%
HV Rank
5.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.57 target)
2
Strong Buy6
Buy1
HoldData last updated: 4/29/2026